Showing results (1211-1220 of 1,278) with videos related to
Sort By:
Pageof 128
Psychopharmacology Bulletin|November 7, 2022
Agomelatine Monotherapy for Autism-A Case ReportAhmed Naguy, Saxby Pridmore, Mohammed A Jamali, et al.Psychopharmacology Bulletin|November 7, 2022
Association of Polymorphism with the Steady-State Concentration of Haloperidol in Patients with Alcohol-Induced Psychotic DisordersA A Parkhomenko, M S Zastrozhin, S A Pozdnyakov, et al.Psychopharmacology Bulletin|November 7, 2022
Probable Risperidone-Associated Acute Pancreatitis in a Child with ADHDAhmed Naguy, Reda Roshdy, Bibi AlamiriPsychopharmacology Bulletin|March 28, 2022
A Case Report of Stuttering Induced by Risperidone and ChlorpromazineShabnam SoodPsychopharmacology Bulletin|January 1, 1989
The ratios of serotonin2 and dopamine2 affinities differentiate atypical and typical antipsychotic drugsH Y Meltzer, S Matsubara, J C LeePsychopharmacology Bulletin|January 1, 1989
Partial brain dopamine D2 receptor agonists in the treatment of schizophreniaD Coward, K Dixon, A Enz, et al.Psychopharmacology Bulletin|January 1, 1989
Smooth pursuit eye movements in schizophrenia: effects of neuroleptic treatment and caffeineR E Litman, D W Hommer, T Clem, et al.Psychopharmacology Bulletin|January 1, 1990
Characteristics of placebo response during long-term treatment of panic disorderS R Dager, A Khan, D Cowley, et al.Psychopharmacology Bulletin|January 1, 1990
Gonadal hormones, sex and behaviorU Halbreich, C Z Lemus, J A Lieberman, et al.Psychopharmacology Bulletin|January 1, 1990
Nefazodone: preclinical pharmacology of a new antidepressantA S Eison, M S Eison, J R Torrente, et al.Pageof 128